Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review
review
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
This systematic review characterized the immune cell phenotype of ectopic adenomyosis lesions and compared it with that of eutopic endometrium.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Inflammation is implicated in the symptomatology and the pathogenesis of adenomyosis. Injury at the endo-myometrial interface causes inflammation and may facilitate the invasion of endometrium into the myometrium, forming adenomyosis lesions. Their presence causes local inflammation, resulting in heavy menstrual bleeding, chronic pelvic pain, and subfertility. Immunological differences have been described in the eutopic endometrium from women with adenomyosis compared to healthy endometrium, and differences are also expected in the adenomyotic lesions compared with the correctly sited eutopic endometrium. This systematic review retrieved relevant articles from three databases with additional manual citation chaining from inception to 24th October 2022. Twenty-two eligible studies were selected in accordance with PRISMA guidelines. Risk of bias assessments were performed, and the findings presented thematically. Ectopic endometrial stroma contained an increased density of macrophages compared with eutopic endometrium in adenomyosis. This was associated with an increase in pro-inflammatory cytokines (IL-6, IL-8, ILβ-1, C-X-C Motif Chemokine Receptor 1(CXCR1), Monocyte Chemoattractant Protein-1 (MCP-1)), and an imbalance of anti-inflammatory cytokines (IL-22, IL-37). Cells in ectopic lesions also contained a higher levels of toll-like receptors and immune-mediated enzymes. However, the studies were heterogeneous, with inconsistent reporting of immune cell density within epithelial or stromal compartments, and inclusion of samples from different menstrual cycle phases in the same group for analysis. A detailed understanding of the immune cell phenotypes present in eutopic and ectopic endometrium in adenomyosis and associated dysregulated inflammatory processes will provide further insight into the pathogenesis, to enable identification of fertility-sparing treatments as an alternative to hysterectomy.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (86)
- Abnormally located SSEA1+/SOX9+ endometrial epithelial cells with a basalis-like phenotype in the eutopic functionalis layer may play a role in the pathogenesis of endometriosis via openalex
- Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition via openalex
- Adenomyosis of the inner and outer myometrium are associated with different clinical profiles via openalex
- Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis via openalex
- A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR) via openalex
- Central changes associated with chronic pelvic pain and endometriosis via openalex
- Characterization of endometriosis-associated immune cell infiltrates (EMaICI) via openalex
- Constant Activation of STAT3 Contributes to the Development of Adenomyosis in Females via openalex
- Correlation of LOX‑5 and COX‑2 expression with inflammatory pathology and clinical features of adenomyosis via openalex
- Cytokine Network of Eutopic and Ectopic Endometrium in Women with Adenomyosis via openalex
- Cytokine Profiling in the Eutopic Endometrium of Adenomyosis During the Implantation Window After Ovarian Stimulation via openalex
- Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis via openalex
- Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis via openalex
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Epithelial Cells in Endometriosis and Adenomyosis Upregulate STING Expression via openalex
- Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis via openalex
- Exploration the global single-cell ecological landscape of adenomyosis-related cell clusters by single-cell RNA sequencing via openalex
- Expression and possible role of interleukin-10 receptors in patients with adenomyosis via openalex
- Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis via openalex
- Expression of CXCL12 and its receptor CXCR4 in patients with adenomyosis via openalex
- Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-2 in Adenomyosis and Endometrial Polyps and its Correlation With Angiogenesis via openalex
- Expression of Inflammatory and Neurogenic Mediators in Adenomyosis: A Pathogenetic Role via openalex
- Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis via openalex
- Expression of interleukin-8 receptors in patients with adenomyosis via openalex
- Expression of Vascular Endothelial Growth Factor (VEGF), Hypoxia Inducible Factor-1α (HIF-1α), and Microvessel Density in Endometrial Tissue in Women With Adenomyosis via openalex
- Expression of γδT Cells and Adhesion Molecules in Endometriotic Tissue in Patients With Endometriosis and Adenomyosis via openalex
- Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification via openalex
- Granulocyte Macrophage Colony-Stimulating Factor in Adenomyosis and Autologous Endometrium via openalex
- HLA-G is upregulated in advanced endometriosis via openalex
- Identifying Common Pathogenic Features in Deep Endometriotic Nodules and Uterine Adenomyosis via openalex
- Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium via openalex
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner. via openalex
- LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis via openalex
- Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human Adenomyosis via openalex
- Neuroendocrine and stress-related aspects of endometriosis. via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Single-cell transcriptomic analysis of eutopic endometrium and ectopic lesions of adenomyosis via openalex
- The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages via openalex
- The effect of pre-analytical variables on downstream application and data analysis of human endometrial biopsies via openalex
- The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis via openalex
- The Expression of Toll-like receptors in eutopic and ectopic endometrium and its implication in the inflammatory pathogenesis of adenomyosis via openalex
- The importance of the macrophage within the human endometrium via openalex
- The pathophysiology of endometriosis and adenomyosis: tissue injury and repair via openalex
- The symptomatology of adenomyosis via openalex
- Transcriptome sequencing of adenomyosis eutopic endometrium: A new insight into its pathophysiology via openalex
- Transvaginal sonographic features of diffuse adenomyosis in 18–30‐year‐old nulligravid women without endometriosis: association with symptoms via openalex
- Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations via openalex
- What if deep endometriotic nodules and uterine adenomyosis were actually two forms of the same disease? via openalex
- W2164410268 via openalex
- W2157339124 via openalex
- W2140455334 via openalex
- W2133376231 via openalex
- W2124080049 via openalex
- W2116475791 via openalex
- W2114428497 via openalex
- W2111984223 via openalex
- W2103385168 via openalex
- W2922267617 via openalex
- W2080671719 via openalex
- W2979621416 via openalex
- W2980789836 via openalex
- W2058218898 via openalex
- W2045302333 via openalex
- W2043916892 via openalex
- W3022751873 via openalex
- W3031654633 via openalex
- W2030284622 via openalex
- W2029675712 via openalex
- W3141256924 via openalex
- W3191480438 via openalex
- W2013257770 via openalex
- W4200241893 via openalex
- W1988142062 via openalex
- W4229052532 via openalex
- W1971599842 via openalex
- W1970187455 via openalex
- W1918962518 via openalex
- W6601083969 via openalex
- W6659363995 via openalex
- W6703470536 via openalex
- W6703746620 via openalex
- W6712901774 via openalex
- W6756492846 via openalex
- W2401206178 via openalex
- W6838897650 via openalex
- W2413704878 via openalex
Cited by (7)
- Spatial and single-cell transcriptomics landscape of adenomyosis 2025
- Spatial and single-cell transcriptomics landscape of adenomyosis 2025
- Spatial and single-cell transcriptomics landscape of adenomyosis 2025
- Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review 2025
- Prevalence and risk factors for chronic endometritis in patients with adenomyosis and infertility: a retrospective cohort study 2024
- The pathogenesis of endometriosis and adenomyosis: insights from single-cell RNA sequencing† 2024
- Establishment of an immortalized cell line derived from human adenomyosis ectopic lesions 2023
Source provenance
- europepmc
- last seen: 2026-06-13T17:20:28.795615+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-06-13T17:19:39.573886+00:00
- unpaywall
- last seen: 2026-06-13T17:26:54.343160+00:00
License: CC0
· commercial use OK